Pharmacokinetics Characteristics of Clomiphene Citrate in Patients with Polycystic Ovary Syndrome (PCOS)
BACKGROUND AND OBJECTIVE: There are no pharmacokinetic data on CC isomers zuclomiphene (Zu) and enclomiphene (En) in patients receiving the drug, mainly women with polycystic ovary disease (PCOS). Thus, the main purpose of this study was to characterize the pharmacokinetics of Zu and En isomers and...
Guardado en:
Autores principales: | N Mirhosseini, N Najafi, MR Shiran, AA Moghadamnia |
---|---|
Formato: | article |
Lenguaje: | EN FA |
Publicado: |
Babol University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/212a01a30344458c9797037c94f8c35c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
COMPARISON OF LETROZOLE AND CLOMIPHENE CITRATE FOR INDUCTION OF OVULATION IN PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME
por: M Zeinalzadeh,, et al.
Publicado: (2008) -
Comparison of Tamoxifen and Clomiphene on Ovulation and Pregnancy Rates in Polycystic Ovary Syndrome Patients
por: S Esmaeilzadeh,, et al.
Publicado: (2009) -
COMPARISON OF OVULATION INDUCTION LETROZOLE AND CLOMIPHENE CITRATE IN SUBFERTILE WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
por: Amna Shafiq, et al.
Publicado: (2021) -
Molecular Mechanisms of Endometrial Functioning in Women with Polycystic Ovary Syndrome
por: A. Yu. Sambyalova
Publicado: (2021) -
The Effect of Different Doses of Clomiphen Citrate on Morphology and Proliferation of Human Endometrial Stromal Cells in In-Vitro Culture
por: M Khazaei,, et al.
Publicado: (2010)